How much does it cost to take Pemigatinib a month?

Pemigatinib, a selective FGFR1-3 inhibitor, is indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma (CCA) (FGFR2 fusions or other rearrangements detected by an FDA-approved test); it is the first targeted therapy to receive regulatory approval for the treatment of CCA. Patients usually take 13.5 mg of pemetinib once daily for 14 days. There will then be a 7-day break to allow the body to recover, and then pemetinib will be taken again daily for 14 days, followed by another 7-day break. This is a treatment phase that can continue as long as the patient benefits from it and the side effects are manageable. The patient should take the drug at the same time every day. Calculated based on the 13.5mg*14 tablets per box, you may need to take about 2 boxes per month.

The original drug Pemetinib has been launched in China and has not yet entered the scope of medical insurance. The price of a box of 9mg*14 tablets of the standard size may be around 50,000 yuan, which can be roughly calculated to cost around 100,000 yuan per month. For families with heavy financial burdens, the expensive price will increase their pressure. The price of the original drug Pemetinib, which is marketed overseas, is 13.5mg*14 tablets per box, which may be around RMB 70,000 (the price may fluctuate due to exchange rates). There are also generic pemetinib drugs produced in other countries overseas. For example, the price of a box of 4.5mg*21 tablets produced by a Laos pharmaceutical factory may be around 3,000 yuan (the price may fluctuate due to the exchange rate). The price is relatively cheap. The drug ingredients of the generic drugs are basically the same as those of the original drugs at home and abroad. According to a rough calculation, the number of patients per month may be less than 10,000. For more drug information and specific prices, please consult Yaode Medical Consultant.